MedTrace Logo

Early Access to ART for All in Swaziland: Effects on Economic Outcomes

NCT03789448 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3019

Last updated 2019-01-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of offering early antiretroviral therapy to HIV-positive individuals in government-managed health facilities in Swaziland on a range of economic outcomes

Conditions

Interventions

OTHER

Early Access to ART for All

All HIV-positive individuals will be initiated on Swaziland's recommended first-line ART regimen, unless contraindicated when recommended alternate regimens will be used per national guidelines

Sponsors & Collaborators

  • Clinton Health Access Initiative Inc.

    collaborator OTHER

  • Till Bärnighausen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-01
Primary Completion
2017-08-31
Completion
2017-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03789448 on ClinicalTrials.gov